(VIANEWS) – Martin Marietta Materials (MLM), Burlington Stores (BURL), Build (BBW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Martin Marietta Materials (MLM)
19.9% sales growth and 13.54% return on equity
Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally. It offers crushed stone, sand, and gravel products; ready mixed concrete and asphalt; paving products and services; and Portland and specialty cement for use in the infrastructure projects, and nonresidential and residential construction markets, as well as in the railroad, agricultural, utility, and environmental industries. The company also produces magnesia-based chemicals products; dolomitic lime primarily to customers for steel production and soil stabilization; and cement treated materials. Its chemical products are used in flame retardants, wastewater treatment, pulp and paper production, and other environmental applications. Martin Marietta Materials, Inc. was founded in 1939 and is headquartered in Raleigh, North Carolina.
Earnings Per Share
As for profitability, Martin Marietta Materials has a trailing twelve months EPS of $17.71.
PE Ratio
Martin Marietta Materials has a trailing twelve months price to earnings ratio of 25.78. Meaning, the purchaser of the share is investing $25.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.54%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 28.8% and 33.9%, respectively.
2. Burlington Stores (BURL)
10.7% sales growth and 36.39% return on equity
Burlington Stores, Inc. operates as a retailer of branded apparel products in the United States. The company provides fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, footwear, accessories, toys, gifts, and coats, as well as baby, home, and beauty products. It operates stores under the Burlington Stores, and Cohoes Fashions brand names in Puerto Rico. Burlington Stores, Inc. was founded in 1972 and is headquartered in Burlington, New Jersey.
Earnings Per Share
As for profitability, Burlington Stores has a trailing twelve months EPS of $4.05.
PE Ratio
Burlington Stores has a trailing twelve months price to earnings ratio of 32.69. Meaning, the purchaser of the share is investing $32.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.39%.
Yearly Top and Bottom Value
Burlington Stores’s stock is valued at $132.38 at 19:22 EST, way under its 52-week high of $239.94 and way above its 52-week low of $115.66.
Sales Growth
Burlington Stores’s sales growth for the next quarter is 10.7%.
3. Build (BBW)
9.6% sales growth and 50.47% return on equity
Build-A-Bear Workshop, Inc. operates as a multi-channel retailer of plush animals and related products. The company operates through three segments: Direct-to-Consumer, International Franchising, and Commercial. Its merchandise comprises various styles of plush products to be stuffed, pre-stuffed plush products, and sounds and scents that can be added to the stuffed animals, as well as range of clothing, shoes, accessories, and other toy and novelty items. The company operates its stores under the Build-A-Bear Workshop brand name; and sells its products through its e-commerce sites. As of January 30, 2021, it operated 354 stores, including 305 stores in the United States and Canada; and 49 stores in the United Kingdom, Ireland, and China, as well as 71 franchised stores internationally. The company was founded in 1997 and is headquartered in St. Louis, Missouri.
Earnings Per Share
As for profitability, Build has a trailing twelve months EPS of $3.45.
PE Ratio
Build has a trailing twelve months price to earnings ratio of 7.1. Meaning, the purchaser of the share is investing $7.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.47%.
4. Incyte Corporation (INCY)
9.2% sales growth and 9.28% return on equity
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults with intermediate or high-risk myelofibrosis; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include axatilimab, an anti-CSF-1R monoclonal antibody being developed as a therapy for patients with chronic GVHD as well as in additional immune-mediated diseases; and parsaclisib, a PI3Kd inhibitor which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It also develops retifanlimab, is in Phase III clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer, and Fast Track designation for the treatment of metastatic MSI-H or DNA mismatch repair (dMMR) endometrial cancer; and INCB99280 and INCB99318 currently under Phase I for the treatment solid tumors. It has collaboration out- license agreements with Novartis, Lilly, Innovent, InnoCare, Maruho, and CMS Aesthetics Limited; and in- license agreements with Agenus, Merus, MacroGenics, Syros, MorphoSys, and Syndax. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Earnings Per Share
As for profitability, Incyte Corporation has a trailing twelve months EPS of $1.88.
PE Ratio
Incyte Corporation has a trailing twelve months price to earnings ratio of 28.13. Meaning, the purchaser of the share is investing $28.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.28%.
5. Armada Hoffler Properties (AHH)
9.1% sales growth and 8.73% return on equity
Armada Hoffler Properties, Inc. (NYSE: AHH) is a vertically-integrated, self-managed real estate investment trust ("REIT") with four decades of experience developing, building, acquiring, and managing high-quality, institutional-grade office, retail, and multifamily properties located primarily in the Mid-Atlantic and Southeastern United States. In addition to developing and building properties for its own account, the Company also provides development and general contracting construction services to third-party clients. Founded in 1979 by Daniel A. Hoffler, the Company has elected to be taxed as a REIT for U.S. federal income tax purposes.
Earnings Per Share
As for profitability, Armada Hoffler Properties has a trailing twelve months EPS of $0.68.
PE Ratio
Armada Hoffler Properties has a trailing twelve months price to earnings ratio of 14.69. Meaning, the purchaser of the share is investing $14.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.73%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 76.3% and a negative 23.1%, respectively.
Volume
Today’s last reported volume for Armada Hoffler Properties is 205153 which is 27.92% below its average volume of 284635.
Revenue Growth
Year-on-year quarterly revenue growth grew by 59.8%, now sitting on 577.56M for the twelve trailing months.
6. Westinghouse Air Brake Technologies Corporation (WAB)
6.8% sales growth and 7.56% return on equity
Westinghouse Air Brake Technologies Corporation provides technology-based locomotives, equipment, systems, and services for the freight rail and passenger transit industries worldwide. The company operates in two segments, Freight and Transit. The Freight segment manufactures and services components for freight cars and locomotives; builds, rebuilds, upgrades, and overhauls locomotives; supplies railway electronics, positive train control equipment, and signal design and engineering services; services locomotives and freight cars; and provides heat exchange and cooling systems, and components and digital solutions. It serves publicly traded railroads; leasing companies; manufacturers of original equipment; and utilities. The Transit segment offers components for new and existing passenger transit vehicles, such as regional and high speed trains, subway cars, light-rail vehicles, and buses; refurbishes subway cars; and provides heating, ventilation, and air conditioning equipment, as well as doors for buses and subways. This segment serves public transit authorities and municipalities, leasing companies, and manufacturers of subway cars and buses. The company also provides electronically controlled pneumatic braking products; freight car trucks; draft gears, couplers, and slack adjusters; air compressors and dryers; track and switch products; railway and freight braking equipment and related components; friction products; access and platform screen doors; pantographs; energy measuring systems; auxiliary power converter and battery charging products; antifire systems; passenger information systems and CCTV; signaling and railway electric relays; sanitation systems; window assemblies; accessibility lifts and ramps for buses; and electric charging solutions for buses and electric ferries. In addition, it offers freight locomotive overhaul, modernizations, and refurbishment services. The company was founded in 1869 and is headquartered in Pittsburgh, Pennsylvania.
Earnings Per Share
As for profitability, Westinghouse Air Brake Technologies Corporation has a trailing twelve months EPS of $4.2.
PE Ratio
Westinghouse Air Brake Technologies Corporation has a trailing twelve months price to earnings ratio of 25.28. Meaning, the purchaser of the share is investing $25.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.56%.
Moving Average
Westinghouse Air Brake Technologies Corporation’s value is under its 50-day moving average of $106.59 and above its 200-day moving average of $104.31.
Yearly Top and Bottom Value
Westinghouse Air Brake Technologies Corporation’s stock is valued at $106.17 at 19:22 EST, way under its 52-week high of $119.70 and way higher than its 52-week low of $88.91.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.5%, now sitting on 9.46B for the twelve trailing months.
7. The Joint Corp. (JYNT)
6.1% sales growth and 10.61% return on equity
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of January 27, 2021, the company operated approximately 550 locations in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Earnings Per Share
As for profitability, The Joint Corp. has a trailing twelve months EPS of $0.27.
PE Ratio
The Joint Corp. has a trailing twelve months price to earnings ratio of 29.26. Meaning, the purchaser of the share is investing $29.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.61%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 111.74M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 33.3% and a negative 25%, respectively.
8. UFP Technologies (UFPT)
5.7% sales growth and 16.76% return on equity
UFP Technologies, Inc. designs and converts foams, films, and plastics materials for the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets in the United States. It offers single patient use surfaces, advanced wound care, infection prevention, and disposables for surgical procedures, endoscopic procedures, orthopedic implants, orthopedic appliances, biopharma drug manufacturing, etc.; molded components for automotive, aerospace, and defense markets; recycled protective packaging for B2C brands; and reusable cases and custom inserts. The company markets and sells its products through direct sales forces and independent manufacturer representatives. UFP Technologies, Inc. was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Earnings Per Share
As for profitability, UFP Technologies has a trailing twelve months EPS of $6.46.
PE Ratio
UFP Technologies has a trailing twelve months price to earnings ratio of 22.16. Meaning, the purchaser of the share is investing $22.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.76%.
Sales Growth
UFP Technologies’s sales growth is 18.2% for the present quarter and 5.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
UFP Technologies’s EBITDA is 90.79.
